Carlos Escobar (Carlos Escobar Cervantes, Carlos Escobar-Cervantes)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 39

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Cardiovascular Disease

Top Venues

Journal of clinical medicine

Future cardiology

Medicina (Kaunas, Lithuania)

Clinical kidney journal

This page only lists publications with an associated author ORCID identifier.

Publications

Jose María Mostaza, Carlos Escobar
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk. Journal of clinical medicine 13 (7) (2024)
Antonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar, Ezequiel Arranz-Martínez, Vicente Pallarés-Carratalá
Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular-Kidney-Metabolic Factors: SIMETAP-AF Study. Medicina (Kaunas, Lithuania) 60 (8) (2024)
Jose María Mostaza, Carlos Escobar
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk. Journal of clinical medicine 13 (7) (2024)
Antonio Ruiz-García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, Carlos Escobar, Vicente Pallarés-Carratalá
Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU Study. Journal of clinical medicine 13 (16) (2024)
Jose María Mostaza, Carlos Escobar
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk. Journal of clinical medicine 13 (7) (2024)
Carlos Escobar, Beatriz Palacios, Miriam Villarreal, Martín Gutiérrez, Margarita Capel, Ignacio Hernández, María García, Laura Lledó, Juan Francisco Arenillas
Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study. Journal of clinical medicine 13 (6) (2024)
Carlos Escobar, Beatriz Palacios, Miriam Villarreal, Martín Gutiérrez, Margarita Capel, Unai Aranda, Ignacio Hernández, María García, Laura Lledó, Juan Francisco Arenillas
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. Journal of clinical medicine 13 (14) (2024)
Carlos Escobar, Beatriz Palacios, Miriam Villarreal, Martín Gutiérrez, Margarita Capel, Unai Aranda, Ignacio Hernández, María García, Laura Lledó, Juan Francisco Arenillas
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. Journal of clinical medicine 13 (14) (2024)
Carlos Escobar, Beatriz Palacios, Miriam Villarreal, Martín Gutiérrez, Margarita Capel, Unai Aranda, Ignacio Hernández, María García, Laura Lledó, Juan Francisco Arenillas
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. Journal of clinical medicine 13 (14) (2024)
Antonio Ruiz-García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, Carlos Escobar, Vicente Pallarés-Carratalá
Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU Study. Journal of clinical medicine 13 (16) (2024)
Carlos Escobar, Beatriz Palacios, Miriam Villarreal, Martín Gutiérrez, Margarita Capel, Ignacio Hernández, María García, Laura Lledó, Juan Francisco Arenillas
Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study. Journal of clinical medicine 13 (6) (2024)
Manuel Montero-Pérez-Barquero, Carlos Escobar, Pau Llàcer, Raúl Quirós-López, Joan C Trullás, Jose M Cerqueiro, Francisco Epelde-Gonzálo, Margarita Carrera-Izquierdo, Francesc Formiga, Alvaro González-Franco, Jesús Casado-Cerrada
Projected clinical benefits of dapagliflozin in patients with heart failure with preserved ejection fraction. Future cardiology (2023)
Cecilia Suárez Carantoña, Carlos Escobar, Martín Fabregate, Mónica López Rodríguez, Nuria Bara Ledesma, Javier Soto Pérez-Olivares, Raúl Antonio Ruiz Ortega, Genoveva López Castellanos, Andreina Olavarría Delgado, Javier Blázquez Sánchez, Vicente Gómez Del Olmo, Myriam Moralejo Martín, María Belén Pumares Álvarez, María de la Concepción Sánchez Gallego, Pau Llàcer, Fernando Liaño, Luis Manzano
Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial. Journal of clinical medicine 12 (8) (2023)
Antonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar, Ezequiel Arranz-Martínez, Miguel Turégano-Yedro, Vicente Pallarés-Carratalá
Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study. Journal of clinical medicine 12 (15) (2023)
Carlos Escobar, Domingo Pascual Figal, Luis Manzano, Julio Nunez, Miguel Camafort
Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin. Journal of clinical medicine 12 (21) (2023)
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R Hunt, Juan Francisco Delgado
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction. Journal of clinical medicine 12 (6) (2023)
Cecilia Suárez Carantoña, Carlos Escobar, Martín Fabregate, Mónica López Rodríguez, Nuria Bara Ledesma, Javier Soto Pérez-Olivares, Raúl Antonio Ruiz Ortega, Genoveva López Castellanos, Andreina Olavarría Delgado, Javier Blázquez Sánchez, Vicente Gómez Del Olmo, Myriam Moralejo Martín, María Belén Pumares Álvarez, María de la Concepción Sánchez Gallego, Pau Llàcer, Fernando Liaño, Luis Manzano
Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial. Journal of clinical medicine 12 (8) (2023)
Manuel Montero-Pérez-Barquero, Carlos Escobar, Melitón Francisco Dávila-Ramos, Iván Suárez-Pedreira, José Pérez-Silvestre, Luis Miguel Ceresuela-Eito, Alberto Muela-Molinero, María Angustias Quesada-Simón, Francesc Formiga, Alvaro González-Franco, Jesús Casado-Cerrada
Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry. Future cardiology (2023)
Cecilia Suárez Carantoña, Carlos Escobar, Martín Fabregate, Mónica López Rodríguez, Nuria Bara Ledesma, Javier Soto Pérez-Olivares, Raúl Antonio Ruiz Ortega, Genoveva López Castellanos, Andreina Olavarría Delgado, Javier Blázquez Sánchez, Vicente Gómez Del Olmo, Myriam Moralejo Martín, María Belén Pumares Álvarez, María de la Concepción Sánchez Gallego, Pau Llàcer, Fernando Liaño, Luis Manzano
Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial. Journal of clinical medicine 12 (8) (2023)
Juan A Divison-Garrote, Julio A Carbayo-Herencia, Marta Simarro-Rueda, Francisca Molina-Escribano, Carlos Escobar, Luis M Artigao-Rodenas, Vicente Gil-Guillén, Jose Ramón Banegas
Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019. Hypertension (Dallas, Tex. : 1979) (2023)
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R Hunt, Juan Francisco Delgado
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction. Journal of clinical medicine 12 (6) (2023)
Vicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, Juan Antonio Divisón-Garrote, Ana Moyá-Amengual, Carlos Escobar, Vivencio Barrios
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study. Medicina (Kaunas, Lithuania) 59 (10) (2023)
Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz, Maria Rosa Fernández Olmo, Carlos Morillas Ariño, Juan José Gómez Doblas, Jose Luis Gorriz Teruel, Pilar Mazón Ramos, Xavier García-Moll, Maria Jose Soler Romeo, David León Jiménez, Vicente Arrarte Esteban, Juan Carlos Obaya Rebollar, Carlos Escobar, Juan José Gorgojo-Martínez
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes. Journal of clinical medicine 12 (12) (2023)
Cecilia Suárez Carantoña, Carlos Escobar, Martín Fabregate, Mónica López Rodríguez, Nuria Bara Ledesma, Javier Soto Pérez-Olivares, Raúl Antonio Ruiz Ortega, Genoveva López Castellanos, Andreina Olavarría Delgado, Javier Blázquez Sánchez, Vicente Gómez Del Olmo, Myriam Moralejo Martín, María Belén Pumares Álvarez, María de la Concepción Sánchez Gallego, Pau Llàcer, Fernando Liaño, Luis Manzano
Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial. Journal of clinical medicine 12 (8) (2023)
Manuel Montero-Pérez-Barquero, Carlos Escobar, José Carlos Arévalo-Lorido, Alicia Conde-Martel, Prado Salamanca-Bautista, Luis Manzano-Espinosa, Francesc Formiga, Jesús Díez-Manglano, José María Cepeda, Alvaro González-Franco, Jesús Casado-Cerrada
Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice. Future cardiology (2023)
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R Hunt, Juan Francisco Delgado
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction. Journal of clinical medicine 12 (6) (2023)
Carlos Escobar, Alberto Esteban Fernández, Alejandro Recio Mayoral, Sonia Mirabet, José González Costello, Jorge Rubio Gracia, Julio Villota Núñez, Álvaro González Franco, Juan Luis Bonilla Palomas
Identifying the patient with heart failure to be treated with vericiguat. Current medical research and opinion (2023)
Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz, Maria Rosa Fernández Olmo, Carlos Morillas Ariño, Juan José Gómez Doblas, Jose Luis Gorriz Teruel, Pilar Mazón Ramos, Xavier García-Moll, Maria Jose Soler Romeo, David León Jiménez, Vicente Arrarte Esteban, Juan Carlos Obaya Rebollar, Carlos Escobar, Juan José Gorgojo-Martínez
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes. Journal of clinical medicine 12 (12) (2023)
Roberto Alcázar, Carlos Escobar, Beatriz Palacios, Unai Aranda, Luis Varela, Margarita Capel, Antoni Sicras, Aram Sicras, Antonio Hormigo, Nicolás Manito, Manuel Botana
Risk of outcomes in a Spanish population with chronic kidney disease. Clinical kidney journal 15 (7) (2022)
Carlos Escobar, Beatriz Palacios, Luis Varela, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R Hunt, Juan Francisco Delgado
Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain. Journal of clinical medicine 11 (17) (2022)
Ana Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras, Aram Sicras, Antonio Hormigo, Nicolás Manito, Manuel Botana, Roberto Alcázar
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease. Clinical kidney journal 15 (6) (2022)
Carlos Escobar, Vivencio Barrios, Gregory Y H Lip, Alpesh N Amin, Ariadna Auladell-Rispau, Marilina Santero, Josefina Salazar, Carolina Requeijo
Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis. Clinical drug investigation 41 (11) (2021)
Carlos Escobar, A John Camm
Changing paradigms: from prevention of thromboembolic events to improved survival in patients with atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 23 (6) (2021)
Vivencio Barrios, Carlos Escobar
Canagliflozin: metabolic, cardiovascular and renal protection. Future cardiology 17 (3) (2021)
Carlos Escobar, Vivencio Barrios
Revisiting Hypertension in Rural Areas: A New Approach Is Required. American journal of hypertension 34 (9) (2021)
Vivencio Barrios, Carlos Escobar, Gonzalo Barón, Juanjo Gómez-Doblas, Esther Recalde, Luis Segura, Pere Alvarez, Francisco Alonso, Jesús Toril, José Miguel Chopo
Quality of life, medication adherence and satisfaction with anticoagulant treatment (dabigatran vs vitamin K antagonists) according to thromboembolic risk. Data from the CAPANA study. International journal of clinical practice 74 (11) (2021)
Carlos Escobar, Luis Varela, Beatriz Palacios, Margarita Capel, Antoni Sicras, Aram Sicras, Antonio Hormigo, Roberto Alcázar, Nicolás Manito, Manuel Botana
Costs and healthcare utilisation of patients with heart failure in Spain. BMC health services research 20 (1) (2020)
Vivencio Barrios, Carlos Escobar, Luis Prieto, Jose Polo, Javier Muñiz García, Manuel Anguita, Gregory Y H Lip
A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score. Future cardiology 17 (4) (2020)
Carlos Escobar, Xavier Borrás, Ramón Bover Freire, Carlos González-Juanatey, Miren Morillas, Alfonso Valle Muñoz, Juan José Gómez-Doblas
A Delphi consensus on the management of oral anticoagulation in patients with non-valvular atrial fibrillation in Spain: ACOPREFERENCE study. PloS one 15 (6) (2020)